Page last updated: 2024-08-23

paclitaxel and Leukemia, Megakaryocytic

paclitaxel has been researched along with Leukemia, Megakaryocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
deFazio, A; Guminski, AD; Harnett, PR	1

Other Studies

1 other study(ies) available for paclitaxel and Leukemia, Megakaryocytic

Article	Year
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia. Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Cell Survival; DNA Adducts; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Humans; Leukemia, Megakaryoblastic, Acute; Paclitaxel; Thrombocytopenia; Tumor Cells, Cultured	2001

Article

Year

Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line--a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia.

Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:3

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Division; Cell Survival; DNA Adducts; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Humans; Leukemia, Megakaryoblastic, Acute; Paclitaxel; Thrombocytopenia; Tumor Cells, Cultured

2001